Navacef is indicated for the treatment of the following infections:
- Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
- Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
- Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
- Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
- Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.